These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9279329)

  • 21. Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.
    Ghoshal N; Cali I; Perrin RJ; Josephson SA; Sun N; Gambetti P; Morris JC
    Arch Neurol; 2009 Oct; 66(10):1240-6. PubMed ID: 19822779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Creutzfeldt-Jakob disease in Turkish Jews-demographic and clinical features.
    Menendez L; Milo R; Cohen OS; Chapman J; Rosenmann H; Nitsan Z; Kahana E; Appel S
    Acta Neurol Scand; 2022 Nov; 146(5):586-589. PubMed ID: 35974683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation.
    Chapman J; Brown P; Rabey JM; Goldfarb LG; Inzelberg R; Gibbs CJ; Gajdusek DC; Korczyn AD
    Neurology; 1992 Jun; 42(6):1249-50. PubMed ID: 1351274
    [No Abstract]   [Full Text] [Related]  

  • 24. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
    Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mutation in the prion protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek, and Tunisian origin.
    Korczyn AD; Chapman J; Goldfarb LG; Brown P; Gajdusek DC
    Ann N Y Acad Sci; 1991; 640():171-6. PubMed ID: 1685643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene.
    Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M
    Prion; 2014; 8(5):336-8. PubMed ID: 25495585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients.
    Cardone F; Liu QG; Petraroli R; Ladogana A; D'Alessandro M; Arpino C; Di Bari M; Macchi G; Pocchiari M
    Brain Res Bull; 1999 Aug; 49(6):429-33. PubMed ID: 10483920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation.
    Cohen OS; Prohovnik I; Korczyn AD; Inzelberg R; Nitsan Z; Appel S; Kahana E; Rosenmann H; Chapman J
    Isr Med Assoc J; 2012 Mar; 14(3):162-5. PubMed ID: 22675855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation.
    Chapman J; Ben-Israel J; Goldhammer Y; Korczyn AD
    Neurology; 1994 Sep; 44(9):1683-6. PubMed ID: 7936296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sporadic and familial CJD: classification and characterisation.
    Gambetti P; Kong Q; Zou W; Parchi P; Chen SG
    Br Med Bull; 2003; 66():213-39. PubMed ID: 14522861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
    Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
    PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease.
    Cohen OS; Kimiagar I; Korczyn AD; Nitsan Z; Appel S; Hoffmann C; Rosenmann H; Kahana E; Chapman J
    Eur J Neurol; 2016 May; 23(5):871-7. PubMed ID: 26806765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.
    Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA
    Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Libyan Creutzfeldt-Jakob disease focus in Israel: an epidemiologic evaluation.
    Zilber N; Kahana E; Abraham M
    Neurology; 1991 Sep; 41(9):1385-9. PubMed ID: 1891086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease.
    Friedman-Levi Y; Meiner Z; Canello T; Frid K; Kovacs GG; Budka H; Avrahami D; Gabizon R
    PLoS Pathog; 2011 Nov; 7(11):e1002350. PubMed ID: 22072968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential allelic expression of PrP mRNA in carriers of the E200K mutation.
    Rosenmann H; Halimi M; Kahana I; Biran I; Gabizon R
    Neurology; 1997 Sep; 49(3):851-6. PubMed ID: 9305353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age and origin of the PRNP E200K mutation causing familial Creutzfeldt-Jacob disease in Libyan Jews.
    Colombo R
    Am J Hum Genet; 2000 Aug; 67(2):528-31. PubMed ID: 10889050
    [No Abstract]   [Full Text] [Related]  

  • 38. Inherited prion disease caused by the V210I mutation: transmission to transgenic mice.
    Mastrianni JA; Capellari S; Telling GC; Han D; Bosque P; Prusiner SB; DeArmond SJ
    Neurology; 2001 Dec; 57(12):2198-205. PubMed ID: 11756597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creutzfeldt-Jakob disease among Libyan Jews.
    Korczyn AD
    Eur J Epidemiol; 1991 Sep; 7(5):490-3. PubMed ID: 1761106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.